| Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ... Journal of Experimental Medicine 208 (7), 1389-1401, 2011 | 792 | 2011 |
| Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia V Fulci, S Chiaretti, M Goldoni, G Azzalin, N Carucci, S Tavolaro, ... Blood, The Journal of the American Society of Hematology 109 (11), 4944-4951, 2007 | 633 | 2007 |
| Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia D Rossi, S Rasi, G Fabbri, V Spina, M Fangazio, F Forconi, R Marasca, ... Blood, The Journal of the American Society of Hematology 119 (2), 521-529, 2012 | 560 | 2012 |
| Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia R Foa, A Vitale, M Vignetti, G Meloni, A Guarini, MS De Propris, L Elia, ... Blood, The Journal of the American Society of Hematology 118 (25), 6521-6528, 2011 | 495 | 2011 |
| Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ... Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011 | 491 | 2011 |
| ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a … A Soriani, A Zingoni, C Cerboni, ML Iannitto, MR Ricciardi, ... Blood, The Journal of the American Society of Hematology 113 (15), 3503-3511, 2009 | 489 | 2009 |
| Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia D Rossi, H Khiabanian, V Spina, C Ciardullo, A Bruscaggin, R Famà, ... Blood, The Journal of the American Society of Hematology 123 (14), 2139-2147, 2014 | 423 | 2014 |
| Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ... Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012 | 396 | 2012 |
| Dasatinib–blinatumomab for Ph-positive acute lymphoblastic leukemia in adults R Foà, R Bassan, A Vitale, L Elia, A Piciocchi, MC Puzzolo, M Canichella, ... New England Journal of Medicine 383 (17), 1613-1623, 2020 | 352 | 2020 |
| The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation A Rosa, M Ballarino, A Sorrentino, O Sthandier, FG De Angelis, ... Proceedings of the national academy of sciences 104 (50), 19849-19854, 2007 | 351 | 2007 |
| NOTCH1 mutations in+ 12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis … I Del Giudice, D Rossi, S Chiaretti, M Marinelli, S Tavolaro, S Gabrielli, ... haematologica 97 (3), 437, 2012 | 262 | 2012 |
| Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases S Raponi, M Stefania De Propris, S Intoppa, M Laura Milani, A Vitale, ... Leukemia & lymphoma 52 (6), 1098-1107, 2011 | 243 | 2011 |
| Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease R Foa, M Massaia, S Cardona, AG Tos, A Bianchi, C Attisano, A Guarini, ... Blood 76 (2), 393-400, 1990 | 243 | 1990 |
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia B Falini, MP Martelli, N Bolli, R Bonasso, E Ghia, MT Pallotta, D Diverio, ... Blood 108 (6), 1999-2005, 2006 | 220 | 2006 |
| Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts S Chiaretti, A Vitale, G Cazzaniga, SM Orlando, D Silvestri, P Fazi, ... haematologica 98 (11), 1702, 2013 | 185 | 2013 |
| BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgVH unmutated chronic lymphocytic leukemia (CLL) cells A Guarini, S Chiaretti, S Tavolaro, R Maggio, N Peragine, F Citarella, ... Blood, The Journal of the American Society of Hematology 112 (3), 782-792, 2008 | 179 | 2008 |
| The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response E Orsini, A Guarini, S Chiaretti, FR Mauro, R Foa Cancer research 63 (15), 4497-4506, 2003 | 179 | 2003 |
| Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness M Messina, I Del Giudice, H Khiabanian, D Rossi, S Chiaretti, S Rasi, ... Blood, The Journal of the American Society of Hematology 123 (15), 2378-2388, 2014 | 160 | 2014 |
| Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 … A Vitale, A Guarini, C Ariola, M Mancini, C Mecucci, A Cuneo, F Pane, ... Blood 107 (2), 473-479, 2006 | 156 | 2006 |
| Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells G Gastl, CL Finstad, A Guarini, G Bosl, E Gilboa, NH Bander, ... Cancer research 52 (22), 6229-6236, 1992 | 153 | 1992 |
